ArticleCancers2024

Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.

Didier Decaudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.